Transcutaneous Auricular Vagus Nerve Stimulation May Aid Knee Pain
By Lori Solomon HealthDay Reporter
TUESDAY, May 27, 2025 -- Transcutaneous auricular vagus nerve stimulation (tVNS) may be a safe pain-relieving treatment for people with knee osteoarthritis (OA), according to a pilot study published in the March issue of Osteoarthritis and Cartilage Open.
Kosaku Aoyagi, Ph.D., from the University of Texas at El Paso, and colleagues treated 30 participants with knee OA to a 60-minute session of tVNS.
The researchers reported that all participants completed the intervention without any major side effects. Knee pain, which was assessed on a 0-to-10 numeric rating pain scale during a 20-m walk, was reduced by 1.27 immediately after and by 1.87 at 15 ​minutes after tVNS compared with baseline. There was a trend toward improvement in conditioned pain modulation at both time points. Similarly, there was a trend toward improvement in heart rate variability at both time points. Pressure pain threshold and temporal summation were unchanged after treatment.
"Our preliminary data demonstrated that tVNS may be a safe pain-relieving treatment for people with knee OA," the authors write. "Our findings suggest that improvement of knee pain might be derived from improvement of parasympathetic function and central pain mechanisms as no local therapy was applied. A large study is needed to confirm that tVNS is a novel intervention to ameliorate knee pain in people with knee OA."
One author disclosed ties to a bioelectronic medicine company developing wearable neuromodulation therapies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 -- Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD)...
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
THURSDAY, July 10, 2025 -- Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels, according...
Majority of Patients With Lyme Disease Do Not Follow Up With Clinician
THURSDAY, July 10, 2025 -- Only 34 percent of patients with erythema migrans >5 cm are positive for Lyme disease by a standard two-tier testing (STTT) algorithm, and of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.